Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.

被引：0
|
作者：
de Lange, SM
van Groeningen, CJ
Giaccone, G
Pinedo, HM
Meijer, OWM
Langendijk, JA
Slotman, BJ
机构：
[1] Vrije Univ Amsterdam, Univ Hosp, Dept Med Oncol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Univ Hosp, Dept Radiotherapy, Amsterdam, Netherlands
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
371
引用
收藏
页码：4540S / 4541S
页数：2
相关论文
共 50 条
  • [1] Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer
    de Lange, SM
    van Groeningen, CJ
    Meijer, OWM
    Cuesta, MA
    Langendijk, JA
    van Riel, JMGH
    Pinedo, HM
    Peters, GJ
    Meijer, S
    Slotman, BJ
    Giaccone, G
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (09) : 1212 - 1217
  • [2] GEMCITABINE PLUS RADIOTHERAPY IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Otsuka, T.
    Kamachi, S.
    Akiyama, T.
    Fujimoto, M.
    Kawazoe, S.
    Ureshino, N.
    Watanabe, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 161 - 161
  • [3] Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Mustafa Cengiz
    Faruk Zorlu
    Suayip Yalcin
    Murat Gurkaynak
    I. Lale Atahan
    Ibrahim H. Gullu
    Medical Oncology, 2007, 24 : 239 - 243
  • [4] Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Cengiz, Mustafa
    Zorlu, Faruk
    Yalcin, Suayip
    Gurkaynak, Murat
    Atahan, I. Lale
    Gullu, Ibrahim H.
    MEDICAL ONCOLOGY, 2007, 24 (02) : 239 - 243
  • [5] STEREOTACTIC BODY RADIOTHERAPY AND GEMCITABINE FOR LOCALLY ADVANCED PANCREATIC CANCER
    Mahadevan, Anand
    Jain, Sanjay
    Goldstein, Michael
    Miksad, Rebecca
    Pleskow, Douglas
    Sawhney, Mandeep
    Brennan, Darren
    Callery, Mark
    Vollmer, Charles
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 735 - 742
  • [6] Phase I/II trial of carbon-ion radiotherapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer.
    Shinoto, Makoto
    Yamada, Shigeru
    Yasuda, Shigeo
    Imada, Hiroshi
    Shioyama, Yoshiyuki
    Honda, Hiroshi
    Kamada, Tadashi
    Tsujii, Hirohiko
    Saisho, Hiromitsu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Crane, CH
    Janjan, NA
    Evans, DB
    Wolff, RA
    Ballo, MT
    Milas, L
    Mason, K
    Charnsangavej, C
    Pisters, PWT
    Lee, JE
    Lenzi, R
    Vauthey, JN
    Wong, A
    Phan, T
    Nguyen, Q
    Abbruzzese, JL
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 9 - 18
  • [8] Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    C. H. Crane
    N. A. Janjan
    D. B. Evans
    R. A. Wolff
    M. T. Ballo
    L. Milas
    K. Mason
    C. Charnsangavej
    P. W. T. Pisters
    J. E. Lee
    R. Lenzi
    J. N. Vauthey
    A. Wong
    T. Phan
    Q. Nguyen
    J. L. Abbruzzese
    International Journal of Pancreatology, 2001, 29 : 9 - 18
  • [9] Intra-arterial gemcitabine vs IV gemcitabine PK substudy in patients with locally advanced pancreatic cancer.
    Zureikat, Amer H.
    Pishvaian, Michael J.
    Meredith, Kenneth
    Hatoum, Hassan
    Zervos, Emmanuel E.
    Nazemzadeh, Reza
    Novelli, Paula M.
    Tsobanoudis, Alex
    Agah, Ramtin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 728 - 728
  • [10] Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.
    Nio, K.
    Ueno, H.
    Okusaka, T.
    Morizane, C.
    Hagihara, A.
    Kondo, S.
    Mayahara, H.
    Ito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345